Articles and resources
Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies
Making NIPT accessible to all women
Universal access to NIPT: Cost-effective and precise cell-free DNA testing
Implementation and Validation of a High-Precision, Non-NGS NIPT Platform
The new era of cell-free DNA testing
Products may not be licensed in accordance with the laws in all countries, such as the United States, Canada. Please check with your local representative for availability.
Revvity does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.